Nita Farahany is a leading scholar on the ethical, legal, and social implications of biosciences and emerging technologies, particularly those related to neuroscience and behavioral genetics. At Duke University, she is the director of Duke Science & Society, the Duke MA in Bioethics & Science Policy, and a professor of law and philosophy. In 2010, she was appointed by President Obama to the Presidential Commission for the Study of Bioethical Issues, and continues to serve as a member. Farahany presents her work widely including to audiences at the Judicial Conferences for the Second and Ninth Circuits, the American Association for the Advancement of Science, the American Society for Political and Legal Philosophy, and by testifying before Congress. She is an elected member of the American Law Institute, Chair of the Criminal Justice Section of the American Association of Law Schools, on the Board of the International Neuroethics Society.
Nita Farahany has also participated in:
Prohibit Genetically Engineered Babies - Against
More About Nita Farahany
Farahany discusses the legal, philosophical and social issues arising from developments in the biosciences, particularly related to behavioral genetics and neuroscience.
A report from the PCSBI assessing how to reconcile expected societal benefit from advances in whole genome sequencing with privacy risks that fall to the individuals who share their genomic data. Farahany was a member of the Commission.
Farahany discusses the work of the PCSBI. At 15 minutes in she covers the risks and benefits of synthetic biology.
Most people use stimulants, such as coffee, on a daily basis. What is the difference between those stimulants and cognitive enhancements?
